Página 2 - Melhores Quimioterapia para cancro da próstata médicos - TOP-38 médicos

O Prof. Assoc. Nail Paksoy, oncologista médico no Hospital Medipol Bahçelievler, é especializado em quimioterapia para câncer de próstata com extensa experiência em ensaios clínicos.

• Certificado pela ESMO em Oncologia Médica
• Contribuinte para 8 ensaios clínicos internacionais sobre tratamentos avançados de câncer
• Publicou vários estudos sobre novos protocolos de quimioterapia
• Especializa-se em abordagens de tratamento personalizadas para câncer de próstata

O Dr. Alemdar é especialista em oncologia médica, com foco no tratamento do cancro da próstata no Complexo Hospitalar Medical Park Antalya.

• Certificado em oncologia médica desde 2018
• Vasta experiência em vários hospitais de prestígio
• Formação avançada pela Universidade Akdeniz
• Dedicado a protocolos de quimioterapia personalizados

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Associado de Oncologia Médica na Universidade İstinye, o Dr. Atci é especializado em tratamentos para câncer de próstata avançado.

• Publicou mais de 19 artigos revisados por pares sobre resultados em oncologia
• Membro da Sociedade Americana de Oncologia Clínica (ASCO)
• Coordenador de Educação para a Subárea de Oncologia Médica
• Trabalha no Liv Hospital Topkapı – um centro oncológico de referência

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Mais de 50.000 cirurgias oncológicas realizadas – O Dr. Raj Nagarkar traz uma vasta experiência no tratamento do cancro da próstata no HCG Manavata Cancer Centre.

• Formado no Tata Memorial Hospital e no Royal College of Surgeons
• Envolvido em mais de 200 ensaios clínicos para novos tratamentos
• Foco especial em Oncologia Cirúrgica Mamária e Torácica
• Professor de Subespecialidade DNB em Oncologia Cirúrgica

O Dr. Shaunak Valame apresentou sua pesquisa sobre câncer de estômago no prestigiado Gastrointestinal Cancer Symposium da ASCO.

• Formado em Oncologia Médica no Indraprastha Apollo Hospital
• Especialista nas bases moleculares do câncer e terapias alvo
• Experiência como Registrador em Oncologia Médica no Jawaharlal Nehru Cancer Hospital
• Ministrou palestras na International Winter School of Oncology no AIIMS

Dr. Lalit Banswal realiza cirurgias oncológicas minimamente invasivas com excelentes resultados – no HCG Manavata Cancer Centre.

• Mais de 10 anos de experiência em oncologia cirúrgica
• Realizou mais de 10.000 cirurgias de grande porte
• Treinado em câncer gastrointestinal no Tata Medical Centre
• Publicou vários artigos de pesquisa nacionais e internacionais
• Conhecido pela abordagem ética e amigável ao paciente

O Dr. Shaikh é especializado em cirurgias de câncer oral e reabilitação funcional no HCG Manavata Cancer Centre.

• 3 anos de experiência focada em oncologia cirúrgica
• Fellowship (bolsa de estudo) em Oncologia Cirúrgica de Cabeça e Pescoço
• Especialista em técnicas de preservação de órgãos
• Proficiente em grandes cirurgias maxilofaciais
• Pesquisador publicado na área

Especialista em imunoterapia e terapia metronômica para cancros avançados – A Dra. Kate formou-se no Tata Memorial Hospital, um dos principais centros de oncologia da Índia.

• Especialista em cancros do pulmão, da mama e geniturinários
• Membro da ASCO, ESMO e outras sociedades oncológicas líderes
• Apresentou investigação sobre o cancro do pulmão na Conferência Mundial sobre o Cancro do Pulmão
• Vencedor do prestigiado prémio de viagem WCLC em 2018

O Dr. Chaitainya Borde realizou mais de 30.000 exames de PET e atendeu 1.000 pacientes com cancro da tiroide no HCG Manavata Cancer Centre.

• 12 anos de experiência em medicina nuclear
• Especialista em terapias com radioiodo e Lu-177 RN
• Proficiente em todos os tipos de exames nucleares e PET-CT
• Artigos publicados em várias revistas médicas

O Dr. Sridhar P.S. é especialista em radioterapia e quimioterapia para cancro da próstata no HCG Manavata Cancer Centre.

• Mais de 20 anos de experiência em radioncologia
• Diplomado pelo National Board em radioterapia
• Membro da Association of Radiation Oncology of India
• Ativo na Society for Neuro-Oncology